840 related articles for article (PubMed ID: 8103794)
21. Effects of intrathecally injected histamine receptor antagonists on the antinociception induced by morphine, beta-endorphin, and U50, 488H administered intrathecally in the mouse.
Suh HW; Song DK; Choi YS; Kim YH
Neuropeptides; 1996 Oct; 30(5):485-90. PubMed ID: 8923512
[TBL] [Abstract][Full Text] [Related]
22. Comparisons of descending pain inhibitory pathways activated by beta-endorphin and morphine as characterized by supraspinal and spinal antinociceptive interactions in mice.
Roerig SC; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1988 Dec; 247(3):1107-13. PubMed ID: 2974485
[TBL] [Abstract][Full Text] [Related]
23. Intrathecally injected nicotine enhances the antinociception induced by morphine but not beta-endorphin, D-Pen2,5-enkephalin and U50,488H administered intrathecally in the mouse.
Suh HW; Song DK; Lee KJ; Choi SR; Kim YH
Neuropeptides; 1996 Aug; 30(4):373-8. PubMed ID: 8914864
[TBL] [Abstract][Full Text] [Related]
24. Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1988 May; 245(2):587-93. PubMed ID: 2966856
[TBL] [Abstract][Full Text] [Related]
25. Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse.
Suh HW; Kim YH; Choi YS; Song DK
Peptides; 1995; 16(7):1229-34. PubMed ID: 8545243
[TBL] [Abstract][Full Text] [Related]
26. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
27. Role of nitric oxide/cyclic GMP in i.c.v. administered beta-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse.
Xu JY; Tseng LF
Eur J Pharmacol; 1994 Sep; 262(3):223-31. PubMed ID: 7813587
[TBL] [Abstract][Full Text] [Related]
28. Involvement of supraspinal epsilon and mu opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse.
Xu JY; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1992 Oct; 263(1):246-52. PubMed ID: 1328609
[TBL] [Abstract][Full Text] [Related]
29. Systemic single dose morphine pretreatment desensitizes mice to the spinal antianalgesic action of dynorphin A (1-17).
Fujimoto JM; Holmes B
J Pharmacol Exp Ther; 1990 Jul; 254(1):1-7. PubMed ID: 1973192
[TBL] [Abstract][Full Text] [Related]
30. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
Wu HE; Sun HS; Terashivili M; Schwasinger E; Sora I; Hall FS; Uhl GR; Tseng LF
Eur J Pharmacol; 2006 Feb; 531(1-3):103-7. PubMed ID: 16445907
[TBL] [Abstract][Full Text] [Related]
31. Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: dissociation from gastrointestinal effects in mice.
DeLander GE; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1992 Dec; 263(3):1097-104. PubMed ID: 1335055
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of 3-isobutyl-1-methylxanthine injected intrathecally or intracerebroventricularly on antinociception induced by opioids administered intracerebroventricularly in the mouse.
Suh HW; Sim YB; Choi YS; Song DK; Kim YH
Neuropeptides; 1995 Jun; 28(6):357-63. PubMed ID: 7545269
[TBL] [Abstract][Full Text] [Related]
33. Spinal dynorphin A (1-17): possible mediator of antianalgesic action.
Fujimoto JM; Arts KS; Rady JJ; Tseng LF
Neuropharmacology; 1990 Jul; 29(7):609-17. PubMed ID: 1974711
[TBL] [Abstract][Full Text] [Related]
34. Differential potentiative effects of glutamate receptor antagonists in the production of antinociception induced by opioids administered intrathecally in the mouse.
Suh H; Song D; Huh S; Kim YH
Brain Res Bull; 2000 May; 52(2):143-50. PubMed ID: 10808085
[TBL] [Abstract][Full Text] [Related]
35. Effects of ginsenosides injected intrathecally or intracerebroventricularly on antinociception induced by beta -endorphin administered intracerebroventricularly in the mouse.
Suh HW; Song DK; Huh SO; Kim YH
Neuropeptides; 1999 Apr; 33(2):101-6. PubMed ID: 10657478
[TBL] [Abstract][Full Text] [Related]
36. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
[TBL] [Abstract][Full Text] [Related]
37. Non-NMDA receptor antagonist attenuates antinociception induced by morphine but not beta-endorphin, D-Pen2-D-Pen5-enkephalin, and U50, 488H administered intracerebroventricularly in mice.
Suh HW; Choi YS; Yoo JS; Song DK; Kim YH; Tseng LF
Neuropeptides; 1995 Feb; 28(2):125-9. PubMed ID: 7746356
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO).
Jiang Q; Seyed-Mozaffari A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1993 Mar; 264(3):1021-7. PubMed ID: 7680715
[TBL] [Abstract][Full Text] [Related]
39. Dynorphins other than dynorphin A(1-17) lack spinal antianalgesic activity but do act on dynorphin A(1-17) receptors.
Rady JJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1991 Dec; 259(3):1073-80. PubMed ID: 1684812
[TBL] [Abstract][Full Text] [Related]
40. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
Fang FG; Fields HL; Lee NM
J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
